77°

Topics

Pharmaceutical Industry
Bayer to buy Claritin, other brands from Merck for $14.2 billion
Bayer to buy Claritin, other brands from Merck for $14.2 billion

Bayer plans to buy Merck & Co.'s consumer health business for $14.2 billion, a deal that would expand the German drug maker's range of over-the-counter medications. The deal, announced Tuesday, would give Bayer control over popular household brands such as Claritin, Coppertone and Dr. Scholl's. The pharmaceutical company would also seize the No. 2 spot in the world for nonprescription drugs. "This acquisition marks a major milestone on our path towards global leadership in the attractive nonprescription medicines business," Bayer Chief Executive Marijn Dekkers said in a statement. On Tuesday, Bayer also said it had agreed to a strategic collaboration with Merck...

Loading